Biosimilar Market Share Greater in Medicare Advantage Versus Part B

Analysis shows that biosimilar uptake was up to 2-fold greater in Medicare Advantage coverage than traditional Medicare.

Related Keywords

Yoganand Chillarige ,Linkedin Yoganand Chillarige ,Drug Administration ,Medicare Advantage ,Medicare Advance ,Biosimilars ,Biosimilar ,Medicare ,Advantage ,Part B ,Part C ,Spending ,Fda ,Market ,Costs ,Study ,